日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

COLEC12high tumor-associated macrophages orchestrate lenvatinib resistance and cancer stemness in hepatocellular carcinoma via paracrine NRG1-HER2/HER3 signaling

COLEC12高表达的肿瘤相关巨噬细胞通过旁分泌NRG1-HER2/HER3信号通路调控肝细胞癌的乐伐替尼耐药性和癌症干细胞特性

期刊:Clinical and Molecular Hepatology
影响因子:16.9
doi:10.3350/cmh.2025.1059
Zhang, Jianxing; Qiao, Liang; Wu, Zongfeng; Zuo, Dinglan; Huang, Shanshan; Liu, Shaoru; Huang, Zhenkun; Zeng, Yi; Li, Yu; Yuan, Yichuan; Wang, Chenwei; He, Wei; Qiu, Jiliang; Yuan, Yunfei; Niu, Yi; Li, Binkui
信号转导
免疫/内分泌
细胞生物学
巨噬细胞
HER2
发育与干细胞
巨噬细胞
干细胞
肿瘤
肿瘤免疫
COL
发表日期：2026
文献求助 收藏

Calcium channel blockers increase the risk of aortic aneurysm and dissection.

钙通道阻滞剂会增加主动脉瘤和主动脉夹层的风险。

期刊:Nature Communications
影响因子:15.7
doi:10.1038/s41467-025-68086-5
Ma Tianfeng, Cai Zeyu, Xu Xinming, Cao Long, Wang Ao, Zhang Zhongshuang, Zhang Siting, Huang Zhenkun, Luo Jingjing, Lin Sen, Ge Jiashu, Wang Xinhao, Fu Yi, Yu Fang, Zhou Jing, Wang Lixin, Zhang Hongpeng, Gao Xiang, Guo Wei, Kong Wei
心血管
动脉瘤
发表日期：2025
文献求助 收藏

USP14-mediated metabolic competition impairs CD8+ T cell immunosurveillance in hepatocellular carcinoma

USP14介导的代谢竞争会损害肝细胞癌中CD8+ T细胞的免疫监视功能。

期刊:Proceedings of the National Academy of Sciences of the United States of America
影响因子:9.1
doi:10.1073/pnas.2510576122
Yuan, Yichuan; Niu, Yi; Huang, Zhenkun; Shi, Yunxing; Lin, Zhu; Zuo, Dinglan; Zhong, Chengrui; Li, Kai; Guan, Xin-Yuan; Yuan, Yunfei; Li, Binkui
肿瘤
T细胞
肿瘤免疫
CD8
代谢
USP14
T细胞
SP1
细胞生物学
免疫/内分泌
发表日期：2025
文献求助 收藏

Regulatory factor X1 promotes sorafenib-induced ferroptosis in hepatocellular carcinoma by transcriptional regulation of BECN1.

调控因子 X1 通过转录调控 BECN1 促进索拉非尼诱导的肝细胞癌铁死亡

期刊:Cellular Oncology
影响因子:4.8
doi:10.1007/s13402-024-01017-6
Yang Zhiwen, Yuan Yichuan, Niu Yi, Zuo Dinglan, Liu Wenwu, Li Kai, Shi Yunxing, Qiu Zhiyu, Li Keren, Lin Zhu, Zhong Chengrui, Huang Zhenkun, He Wei, Guan Xinyuan, Yuan Yunfei, Zeng Weian, Qiu Jiliang, Li Binkui
细胞生物学
转录调控
铁死亡
发表日期：2025
文献求助 收藏

Concentrated solar CO2 reduction in H2O vapour with >1% energy conversion efficiency

聚光太阳能将 CO2 还原为水蒸气，能量转换效率 >1%

期刊:Nature Communications
影响因子:14.7
doi:10.1038/s41467-024-49003-8
Yuqi Ren #, Yiwei Fu #, Naixu Li, Changjun You, Jie Huang, Kai Huang, Zhenkun Sun, Jiancheng Zhou, Yitao Si, Yuanhao Zhu, Wenshuai Chen, Lunbo Duan, Maochang Liu
信号转导
发表日期：2024
文献求助 收藏

Biodegradable Ruthenium-Rhenium Complexes Containing Nanoamplifiers: Triggering ROS-Induced CO Release for Synergistic Cancer Treatment

含纳米放大器的可生物降解钌-铼配合物：触发ROS诱导的CO释放以实现协同抗癌治疗

期刊:Advanced Science
影响因子:14.1
doi:10.1002/advs.202403795
Liu, Aijie; Huang, Zhenkun; Du, Xiangfu; Duvva, Naresh; Du, Yuting; Teng, Zihao; Liao, Zhihuan; Liu, Chen; Tian, Haining; Huo, Shuaidong
肿瘤
肿瘤免疫
发表日期：2024
文献求助 收藏

m(6)A-mediated lnc-OXAR promotes oxaliplatin resistance by enhancing Ku70 stability in non-alcoholic steatohepatitis-related hepatocellular carcinoma

m(6)A介导的lnc-OXAR通过增强Ku70稳定性促进非酒精性脂肪性肝炎相关肝细胞癌的奥沙利铂耐药性

期刊:Journal of Experimental & Clinical Cancer Research
影响因子:12.8
doi:10.1186/s13046-024-03134-4
Lin, Zhu; Huang, Zhenkun; Qiu, Jiliang; Shi, Yunxing; Zuo, Dinglan; Qiu, Zhiyu; He, Wei; Niu, Yi; Yuan, Yunfei; Li, Binkui
肿瘤
肿瘤免疫
Ku70
细胞生物学
肝炎
发表日期：2024
文献求助 收藏

PD-L1 inhibitor versus PD-1 inhibitor plus bevacizumab with transvascular intervention in unresectable hepatocellular carcinoma

PD-L1抑制剂与PD-1抑制剂联合贝伐单抗经血管介入治疗不可切除肝细胞癌的比较

期刊:Clinical and Experimental Medicine
影响因子:3.5
doi:10.1007/s10238-024-01415-y
Huang, Zhenkun; Chen, Tiejun; Li, Wenbin; Qiu, Jiliang; Liu, Shaoru; Wu, Zongfeng; Li, Binkui; Yuan, Yunfei; He, Wei
肿瘤
肿瘤免疫
PD-L1
细胞生物学
PD-1
发表日期：2024
文献求助 收藏

Regorafenib with immunotherapy versus regorafenib alone as second-line treatment for hepatocellular carcinoma: A multicenter real-world study

瑞戈非尼联合免疫疗法与单用瑞戈非尼作为肝细胞癌二线治疗方案的比较：一项多中心真实世界研究

期刊:Cancer Medicine
影响因子:3.1
doi:10.1002/cam4.7236
Qiao, Liang; He, Wei; Wang, Guoying; Chen, Huanwei; Huang, Fuxi; Zhang, Bo; Qiu, Yuxiong; Liu, Shaoru; Huang, Zhenkun; Yuan, Yichuan; Qiu, Jiliang; Yuan, Yunfei; Li, Binkui
细胞生物学
肿瘤
肿瘤免疫
免疫/内分泌
发表日期：2024
文献求助 收藏

TACE-HAIC combined with targeted therapy and immunotherapy versus TACE alone for hepatocellular carcinoma with portal vein tumour thrombus: a propensity score matching study

TACE-HAIC联合靶向治疗和免疫治疗与单纯TACE治疗伴门静脉癌栓的肝细胞癌：一项倾向评分匹配研究

期刊:International Journal of Surgery
影响因子:10.1
doi:10.1097/JS9.0000000000000256
Yuan, Yichuan; He, Wei; Yang, Zhiwen; Qiu, Jiliang; Huang, Zhenkun; Shi, Yunxing; Lin, Zhu; Zheng, Yun; Chen, Minshan; Lau, Wan Yee; Li, Binkui; Yuan, Yunfei
细胞生物学
肿瘤
肿瘤免疫
免疫/内分泌
发表日期：2023
文献求助 收藏